Cohance Lifesciences Ltd.

1:1

Employees Stock Option Plan & Bonus issue & Increase in Authorised Capital Inter alia, approved : 1. Issue of Bonus Shares The Board of Directors has considered, approved and recommended issue of (1:1) one Bonus Share for every one equity share held by the equity shareholders of the Company. The bonus issue of equity shares is subject to the approval of the shareholders in the ensuing annual general meeting and any other applicable statutory and regulatory approvals, as may be required. 2. The Second Annual General Meeting of the Company will be held on Monday the 14th day of September, 2020 at 11.30 a.m. IST. The Bonus shares once allotted shall rank pari-passu in all respects and carry the same rights of the existing Equity Shares and shall be entitled to participate in full in any dividend and other corporate action, recommended and declared, if any, after the issue and allotment of such Bonus Shares. 3. The Board of Directors has considered and approved increase in the Authorized Share Capital from Rs. 20.10 crores divided into 20.10 crores equity shares of Rs. 1/- each to Rs. 40.00 crores divided into 40.00 crores equity shares of Rs. 1/- each and consequential alteration in the Memorandum of Association of the Company, subject to the approval of shareholders of the Company. 4. The Board of Directors also approved granting of 10,00,000 (ten lakh only) Employee Stock options of Rs.1/- each under Suven Pharma Employee Stock Option Scheme 2020 (SPLESOP 2020) to the eligible employees of the Company and recommended to the members for their approval in the ensuing Annual General Meeting.